Tyrosine kinase inhibitors and epidermal growth factor receptor (egfr) mutations in non-small cell lung cancer: To test or not to test?

Adi F. Gazdar

Research output: Contribution to journalComment/debatepeer-review

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)168-170
Number of pages3
JournalMedicine
Volume90
Issue number3
DOIs
StatePublished - May 2011

ASJC Scopus subject areas

  • General Medicine

Cite this